These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1665065)

  • 21. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1975 Sep; 42(3):91-8. PubMed ID: 172828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of the proteolytic complex of Clostridium perfringens type A].
    Novoselova GN; Efimova NP
    Prikl Biokhim Mikrobiol; 1976; 12(6):890-903. PubMed ID: 191802
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization and functional assessment of Clostridium histolyticum class I (C1) collagenases and the synergistic degradation of native collagen in enzyme mixtures containing class II (C2) collagenase.
    Breite AG; McCarthy RC; Dwulet FE
    Transplant Proc; 2011 Nov; 43(9):3171-5. PubMed ID: 22099748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some newly characterized collagenases from procaryotes and lower eucaryotes.
    Keil B
    Mol Cell Biochem; 1979 Jan; 23(2):87-108. PubMed ID: 220520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of RNase Y in Clostridium perfringens mRNA Decay and Processing.
    Obana N; Nakamura K; Nomura N
    J Bacteriol; 2017 Jan; 199(2):. PubMed ID: 27821608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of C1q found in a patient with hypocomplementemic vasculitis-urticaria syndrome.
    Sasaki T; Yonemasu K; Matsumoto M; Nagaki K
    Microbiol Immunol; 1989; 33(5):413-22. PubMed ID: 2502705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Degradation of C1q, the first subcomponent of the complement sequence, by synovial collagenase from patients with rheumatoid arthritis (author's transl)].
    Menzel EJ; Smolen JS
    Wien Klin Wochenschr; 1978 Oct; 90(20):727-30. PubMed ID: 213903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an important enzymatic component in collagenase that is essential for the effective digestion of the human and porcine pancreas.
    Chen RL; James RF
    Cell Transplant; 2001; 10(8):709-16. PubMed ID: 11814113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detergent-activation of latent collagenase and resolution of its component molecules.
    Birkedal-Hansen H; Taylor RE
    Biochem Biophys Res Commun; 1982 Aug; 107(4):1173-8. PubMed ID: 6291522
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction and virulence testing of a collagenase mutant of Clostridium perfringens.
    Awad MM; Ellemor DM; Bryant AE; Matsushita O; Boyd RL; Stevens DL; Emmins JJ; Rood JI
    Microb Pathog; 2000 Feb; 28(2):107-17. PubMed ID: 10644496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of 1-anilino-8-naphthalene sulphonate with human C1q.
    Alcolea JM; Antón LC; Marqués G; Sánchez-Corral P; Vivanco F
    Mol Immunol; 1986 Jan; 23(1):39-44. PubMed ID: 3007977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagenase activity in squamous cell carcinoma of the human parotid gland.
    Huang CC; Blitzer A; Abramson M
    Ann Otol Rhinol Laryngol; 1982; 91(2 Pt 1):156-9. PubMed ID: 6282173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns.
    French MF; Mookhtiar KA; Van Wart HE
    Biochemistry; 1987 Feb; 26(3):681-7. PubMed ID: 3032235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
    Morris KM; Aden DP; Knowles BB; Colten HR
    J Clin Invest; 1982 Oct; 70(4):906-13. PubMed ID: 6288774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of toxic enzymes of Clostridium perfringens BP6K on technologically important media including a medium with Tween 80.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):243-8. PubMed ID: 217931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen degradation by three Clostridium histolyticum collagenase fractions with different substrate specificities.
    Vos-Scheperkeuter GH; Vonk MW; Wolters GH; van Schilfgaarde R
    Transplant Proc; 1994 Apr; 26(2):641-2. PubMed ID: 8171590
    [No Abstract]   [Full Text] [Related]  

  • 38. Mammalian collagenases.
    Cawston TE; Murphy G
    Methods Enzymol; 1981; 80 Pt C():711-22. PubMed ID: 6281624
    [No Abstract]   [Full Text] [Related]  

  • 39. Purification and characterization of neuraminidase from Clostridium perfringens.
    Chien CH; Chang SC; Wei YH
    Proc Natl Sci Counc Repub China B; 1989 Jul; 13(3):201-9. PubMed ID: 2556722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
    Su H; Boackle RJ
    Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.